20/20 BIOLABS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
20/20 BIOLABS, INC. (AIDX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $335.17 thousand as of 2026-04-02, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-08-14
- 2026-04-02: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value $335.17K.
- 2024-11-01: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value $440.50K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value |
|---|---|
| 2026-04-02 | $335.17K 10-Q · filed 2026-08-14 |
| 2024-11-01 | $440.50K POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |